An immunotherapy helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found. Pembrolizumab kept cancer at bay for some patients for an ...

Jacqueline joined The Generations Study research team in 2022. Prior to joining the study, she has 14 years of experience working in the NHS in acute hospital, education, and primary care settings, ...

Image: Blood brain barrier from mouse brain tissue. Image provided by the National Cancer Institute. Diffuse midline gliomas (DMGs) are one of the most aggressive and hard-to-treat childhood cancers.

The Institute of Cancer Research, London, has welcomed the approval of a new combination of two drugs for ovarian cancer by the US regulatory body the Food and Drug Administration (FDA). The approval ...

Radiotheranostics is an exciting new field that has the potential to transform how cancers are detected and treated. Robbie Lockyer finds out more. Image: Dr Kathy Chung Ying Chan Radiotheranostics is ...

When personal trainer Gemma Seager, 45, injured her back while lifting weights, she assumed it would improve with rest. But after 10 months of pain, she was diagnosed with myeloma, a type of blood ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...